Specificity and affinity motifs for Grb2 SH2-ligand interactions
- PMID: 12084912
- PMCID: PMC124298
- DOI: 10.1073/pnas.142224499
Specificity and affinity motifs for Grb2 SH2-ligand interactions
Abstract
Protein-protein interactions are often mediated by the recognition of short continuous amino acid stretches on target proteins by specific binding domains. Affinity-based selection strategies have successfully been used to define recognition motifs for a large series of such protein domains. However, in many biological systems specificity of interaction may be of equal or greater importance than affinity. To address this issue we have developed a peptide library screening technology that can be used to directly define ligands for protein domains based on both affinity and specificity of interaction. We demonstrate the value of this approach by the selection of peptide ligands that are either highly specific for the Grb2 Src homology 2 (SH2) domain or that are cross-reactive between a group of related SH2 domains. Examination of previously identified physiological ligands for the Grb2 SH2 domain suggests that for these ligands regulation of the specificity of interaction may be an important factor for in vivo ligand selection.
Figures







Similar articles
-
Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.J Mol Biol. 2002 Feb 1;315(5):1167-77. doi: 10.1006/jmbi.2001.5299. J Mol Biol. 2002. PMID: 11827484
-
Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain.J Med Chem. 1998 Aug 27;41(18):3442-9. doi: 10.1021/jm980159a. J Med Chem. 1998. PMID: 9719597
-
Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.J Mol Biol. 1998 Jun 19;279(4):1013-22. doi: 10.1006/jmbi.1998.1790. J Mol Biol. 1998. PMID: 9642078
-
Grb2 SH2 domain-binding peptide analogs as potential anticancer agents.Biopolymers. 2003;71(2):132-40. doi: 10.1002/bip.10396. Biopolymers. 2003. PMID: 12767115 Review.
-
Progress towards the development of SH2 domain inhibitors.Chem Soc Rev. 2013 Apr 21;42(8):3337-70. doi: 10.1039/c3cs35449k. Epub 2013 Feb 11. Chem Soc Rev. 2013. PMID: 23396540 Review.
Cited by
-
Specificity and regulation of phosphotyrosine signaling through SH2 domains.J Struct Biol X. 2020 May 27;4:100026. doi: 10.1016/j.yjsbx.2020.100026. eCollection 2020. J Struct Biol X. 2020. PMID: 32647828 Free PMC article.
-
An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells.Nat Med. 2016 Sep;22(9):1013-22. doi: 10.1038/nm.4147. Epub 2016 Aug 1. Nat Med. 2016. PMID: 27479084 Free PMC article.
-
The human CD8β M-4 isoform dominant in effector memory T cells has distinct cytoplasmic motifs that confer unique properties.PLoS One. 2013;8(3):e59374. doi: 10.1371/journal.pone.0059374. Epub 2013 Mar 22. PLoS One. 2013. PMID: 23533620 Free PMC article.
-
High-Affinity Interactions of the nSH3/cSH3 Domains of Grb2 with the C-Terminal Proline-Rich Domain of SOS1.J Am Chem Soc. 2020 Feb 19;142(7):3401-3411. doi: 10.1021/jacs.9b10710. Epub 2020 Feb 4. J Am Chem Soc. 2020. PMID: 31970984 Free PMC article.
-
Generating and validating renewable affimer protein binding reagents targeting SH2 domains.Sci Rep. 2024 Nov 16;14(1):28322. doi: 10.1038/s41598-024-79357-4. Sci Rep. 2024. PMID: 39550397 Free PMC article.
References
-
- Sudol M. Oncogene. 1998;17:1469–1474. - PubMed
-
- Anderson D, Koch C A, Grey L, Ellis C, Moran M F, Pawson T. Science. 1990;250:979–982. - PubMed
-
- Songyang Z, Shoelson S E, Chaudhuri M, Gish G, Pawson T, Haser W G, King F, Roberts T, Ratnofsky S, Lechleider R J, et al. Cell. 1993;72:767–778. - PubMed
-
- Oligino L, Lung F D, Sastry L, Bigelow J, Cao T, Curran M, Burke T R, Jr, Wang S, Krag D, Roller P P, et al. J Biol Chem. 1997;272:29046–29052. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous